ConnollyH.M.CraryJ.L.McGoonM.D.Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med.1997 Aug 28; 337(9): 581–8. http://dx.doi.org/10.1056/NEJM199708283370901. PMID: 9271479.
2.
Centers for Disease Control and Prevention (CDC). Cardiac valvulopathy associated with exposure to fenfluramine or dexfenfluramine: U.S. Department of Health and Human Services interim public health recommendations, November 1997. MMWR Morb Mortal Wkly Rep.1997 Nov 14; 46(45): 1061–6. PMID: 9385873.
3.
SteffeeC.H.SinghH.K.ChitwoodW.R.. Histologic changes in three explanted native cardiac valves following use of fenfluramines. Cardiovasc Pathol.1999 Sep-Oct; 8(5): 245–53. http://dx.doi.org/10.1016/S1054-8807(99)00019-8. PMID: 10533956.
4.
VolmarK.E.HutchinsG.M.. Aortic and mitral fenfluramine-phentermine valvulopathy in 64 patients treated with anorectic agents. Arch Pathol Lab Med.2001 Dec; 125(12): 1555–61. PMID: 11735689.
5.
FronteraJ.A.GradonJ.D.. Right-side endocarditis in injection drug users: review of proposed mechanisms of pathogenesis. Clin Infect Dis.2000 Feb; 30(2): 374–9. http://dx.doi.org/10.1086/313664 PMID: 10671344.
6.
McKinseyD.S.RattsT.E.BisnoA.L.. Underlying cardiac lesions in adults with infective endocarditis. The changing spectrum. Am J Med.1987 Apr; 82(4): 681–8. http://dx.doi.org/10.1016/0002-9343(87)90001-5. PMID: 3565426.
7.
KamaledeenA.YoungC.AttiaR.Q.. What are the differences in outcomes between right-sided active infective endocarditis with and without left-sided infection?Interact Cardiovasc Thorac Surg.2012 Feb; 14(2): 205–8. http://dx.doi.org/10.1093/icvts/ivr012. PMID: 22159232. PMCID: PMC3279982.
8.
ArnettE.N.RobertsW.C.. Valve ring abscess in active infective endocarditis. Frequency, location, and clues to clinical diagnosis from the study of 95 necropsy patients. Circulation.1976 Jul; 54(1): 140–5. http://dx.doi.org/10.1161/01.CIR.541.140. PMID: 1277418.
9.
BaddourL.M.WilsonW.R.BayerA.S.Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation.2005 Jun 14; 111(23): e394–434http://dx.doi.org/10.1161/CIRCULATIONAHA.105.165564http://dx.doi.org/10.1161/CIRCULATIONAHA.105.165563. PMID: 15956145.
10.
TunkelA.R.SepkowitzK.A.. Infections caused by viridans streptococci in patients with neutropenia. Clin Infect Dis.2002 Jun 1; 34(11): 1524–9. http://dx.doi.org/10.1086/340402. PMID: 12015700.